Document is current
Any future updates will be listed below
-
Authors
Lilamand, Matthieu https://orcid.org/0000-0002-4622-2413
Decaix, Théodore
Gourraud, Pierre-Antoine
Dufour, Richard
Gavazzi, Gaëtan
Boaddaert, Jacques
Roubaud-Baudron, Claire
Vallet, Hélène
Annweiler, Cédric
Chapelet, Guillaume
- License Information
-
More Information
Article History
Received: 25 July 2025
Revised: 9 October 2025
Accepted: 12 October 2025
First Online: 20 October 2025
Declarations
:
: The authors declare no conflicts of interest. PA Gourraud is the founder of Methodomics (2008) and its spin-off Big data Santé (2018- “Octopize” brand). He consults for major pharmaceutical companies, and start-ups, all of which are handled through academic pipelines (AstraZeneca, Amgen, Biogen, Boston Scientific, Cemka, Cook, Docaposte/Heva, Edimark, Ellipses, Elsevier, Grunenthal, Janssen, IAGE, Lek, Methodomics, Merck, Mérieux, Novartis, Octopize, Sanofi-Genzyme, Lifen, TuneInsight, Aspire UAE). PA Gourraud is a volunteer board member at AXA not-for-profit mutual insurance company (2021). He has no prescription activity with either drugs or devices. He receives no wages from these activities.
